|
|
||||||||
Department of Neurology, The Middlesex Hospital, London, UK.(Drs. Hughes and Lees)
Parkinson's Disease Society Brain Bank, Institute of Neurology, London, UK. (Drs. Hughes, Daniel, and Lees)
Department of Epidemiology and Public Health, University College London, London, UK. (Dr. Ben-Shlomo)
Many authorities have drawn attention to the difficulties in clinically distinguishing Parkinson's disease (PD) from other parkinsonian syndromes. We assessed the clinical features of 100 patients diagnosed prospectively by a group of consultant neurologists as having idiopathic PD according to their pathologic findings. Seventy-six percent of these cases were confirmed to have PD. By using selected criteria (asymmetrical onset, no atypical features, and no possible etiology for another parkinsonian syndrome) the proportion of true PD cases identified was increased to 93%, but 32% of pathologically confirmed cases were rejected on this basis. These observations suggest that studies based on consultant diagnosis of PD, using standard diagnostic criteria, will include cases other than PD, thus distorting results from clinical trials and epidemiologic studies. The strict use of additional criteria can reduce misdiagnosis but at the cost of excluding genuine PD cases.
Address correspondence and reprint requests to Dr. Andrew J. Lees, Department of Neurology, The Middlesex Hospital, Mortimer Street, London WIN 8AA, UK.
Dr. Hughes and Dr. Daniel are funded by the Parkinson's Disease Society, UK. Dr. Ben-Shlomo is a Wellcome research fellow in Clinical Epidemiology.
Received August 9, 1991. Accepted for publication in final form November 5, 1991.
This article has been cited by other articles:
![]() |
R Caslake, J N Moore, J C Gordon, C E Harris, and C Counsell Changes in diagnosis with follow-up in an incident cohort of patients with parkinsonism J. Neurol. Neurosurg. Psychiatry, November 1, 2008; 79(11): 1202 - 1207. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ishihara-Paul, M. M. Hulihan, J. Kachergus, R. Upmanyu, L. Warren, R. Amouri, R. Elango, R. K. Prinjha, A. Soto, M. Kefi, et al. PINK1 mutations and parkinsonism Neurology, September 16, 2008; 71(12): 896 - 902. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Weiner There Is No Parkinson Disease Arch Neurol, June 1, 2008; 65(6): 705 - 708. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Wahner, J. M. Bronstein, Y. M. Bordelon, and B. Ritz Statin use and the risk of Parkinson disease Neurology, April 15, 2008; 70(16_Part_2): 1418 - 1422. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Jankovic Parkinson's disease: clinical features and diagnosis J. Neurol. Neurosurg. Psychiatry, April 1, 2008; 79(4): 368 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bogdanov, W. R. Matson, L. Wang, T. Matson, R. Saunders-Pullman, S. S. Bressman, and M. F. Beal Metabolomic profiling to develop blood biomarkers for Parkinson's disease Brain, February 1, 2008; 131(2): 389 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Wahner, J. M. Bronstein, Y. M. Bordelon, and B. Ritz Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease Neurology, November 6, 2007; 69(19): 1836 - 1842. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Kim, S. Hong, G. P. Kim, Y. J. Choi, Y. K. Kim, S. S. Park, S. E. Kim, and B. S. Jeon Importance of Low-Range CAG Expansion and CAA Interruption in SCA2 Parkinsonism Arch Neurol, October 1, 2007; 64(10): 1510 - 1518. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Wahner, J. S. Sinsheimer, Jeff. M. Bronstein, and B. Ritz Inflammatory Cytokine Gene Polymorphisms and Increased Risk of Parkinson Disease Arch Neurol, June 1, 2007; 64(6): 836 - 840. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ishihara, L. Warren, R. Gibson, R. Amouri, S. Lesage, A. Durr, M. Tazir, Z. K. Wszolek, R. J. Uitti, W. C. Nichols, et al. Clinical Features of Parkinson Disease Patients With Homozygous Leucine-Rich Repeat Kinase 2 G2019S Mutations. Arch Neurol, September 1, 2006; 63(9): 1250 - 1254. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S M Taylor and C. Counsell Is it Parkinson's disease, and if not, what is it? Practical Neurology, June 1, 2006; 6(3): 154 - 165. [Full Text] [PDF] |
||||
![]() |
O. Suchowersky, S. Reich, J. Perlmutter, T. Zesiewicz, G. Gronseth, and W. J. Weiner Practice Parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, April 11, 2006; 66(7): 968 - 975. [Abstract] [Full Text] [PDF] |
||||
![]() |
D R Williams, H C Watt, and A J Lees Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study J. Neurol. Neurosurg. Psychiatry, April 1, 2006; 77(4): 468 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Caviness, J. M. Liss, C. Adler, and V. Evidente Analysis of high-frequency electroencephalographic-electromyographic coherence elicited by speech and oral nonspeech tasks in Parkinson's disease. J Speech Lang Hear Res, April 1, 2006; 49(2): 424 - 438. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Glatt, A. D. Wahner, D. J. White, A. Ruiz-Linares, and B. Ritz Gain-of-function haplotypes in the vesicular monoamine transporter promoter are protective for Parkinson disease in women Hum. Mol. Genet., January 15, 2006; 15(2): 299 - 305. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Oishi, F. Udaka, M. Kameyama, N. Sawamoto, K. Hashikawa, and H. Fukuyama Regional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations Neurology, December 13, 2005; 65(11): 1708 - 1715. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-H. Lee, C.-C. Lee, W.-C. Shyu, P.-N. Chong, and S.-Z. Lin Hyperintense Putaminal Rim Sign Is Not a Hallmark of Multiple System Atrophy at 3T AJNR Am. J. Neuroradiol., October 1, 2005; 26(9): 2238 - 2242. [Abstract] [Full Text] [PDF] |
||||
![]() |
F S Ertan, T Ertan, G Kiziltan, and H Uygucgil Reliability and validity of the Geriatric Depression Scale in depression in Parkinson's disease J. Neurol. Neurosurg. Psychiatry, October 1, 2005; 76(10): 1445 - 1447. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Landau, K. C. Luk, M.-L. Jones, R. Siegrist-Johnstone, Y. K. Young, E. Kouassi, V. V. Rymar, A. Dagher, A. F. Sadikot, and J. Desbarats Defective Fas expression exacerbates neurotoxicity in a model of Parkinson's disease J. Exp. Med., September 6, 2005; 202(5): 575 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Popat, S. K. Van Den Eeden, C. M. Tanner, V. McGuire, A. L. Bernstein, D. A. Bloch, A. Leimpeter, and L. M. Nelson Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease Neurology, August 9, 2005; 65(3): 383 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Oba, A. Yagishita, H. Terada, A. J. Barkovich, K. Kutomi, T. Yamauchi, S. Furui, T. Shimizu, M. Uchigata, K. Matsumura, et al. New and reliable MRI diagnosis for progressive supranuclear palsy Neurology, June 28, 2005; 64(12): 2050 - 2055. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Sturman, D. E. Vaillancourt, and D. M. Corcos Effects of Aging on the Regularity of Physiological Tremor J Neurophysiol, June 1, 2005; 93(6): 3064 - 3074. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Stocchi, L. Vacca, S. Ruggieri, and C. W. Olanow Intermittent vs Continuous Levodopa Administration in Patients With Advanced Parkinson Disease: A Clinical and Pharmacokinetic Study Arch Neurol, June 1, 2005; 62(6): 905 - 910. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Levy, E. D. Louis, L. Cote, M. Perez, H. Mejia-Santana, H. Andrews, J. Harris, C. Waters, B. Ford, S. Frucht, et al. Contribution of Aging to the Severity of Different Motor Signs in Parkinson Disease Arch Neurol, March 1, 2005; 62(3): 467 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. K. Scott, F. Zhang, J. M. Stajich, B. L. Scott, M. A. Stacy, and J. M. Vance Family-based case-control study of cigarette smoking and Parkinson disease Neurology, February 8, 2005; 64(3): 442 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Sturman, D. E. Vaillancourt, L. V. Metman, R. A. E. Bakay, and D. M. Corcos Effects of subthalamic nucleus stimulation and medication on resting and postural tremor in Parkinson's disease Brain, September 1, 2004; 127(9): 2131 - 2143. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Johnson, S. M. Hague, M. Hanson, A. Gibson, K. E. Wilson, E. W. Evans, A. A. Singleton, A. McInerney-Leo, R. L. Nussbaum, D. G. Hernandez, et al. SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies Neurology, August 10, 2004; 63(3): 554 - 556. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Michell, S. J. G. Lewis, T. Foltynie, and R. A. Barker Biomarkers and Parkinson's disease Brain, August 1, 2004; 127(8): 1693 - 1705. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Levy, E. D. Louis, H. Mejia-Santana, L. Cote, H. Andrews, J. Harris, C. Waters, B. Ford, S. Frucht, S. Fahn, et al. Lack of Familial Aggregation of Parkinson Disease and Alzheimer Disease Arch Neurol, July 1, 2004; 61(7): 1033 - 1039. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. J. Li, M. A. Hauser, W. K. Scott, E. R. Martin, M. W. Booze, X. J. Qin, J. W. Walter, M. A. Nance, J. P. Hubble, W. C. Koller, et al. Apolipoprotein E controls the risk and age at onset of Parkinson disease Neurology, June 8, 2004; 62(11): 2005 - 2009. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Thaisetthawatkul, B. F. Boeve, E. E. Benarroch, P. Sandroni, T. J. Ferman, R. Petersen, and P. A. Low Autonomic dysfunction in dementia with Lewy bodies Neurology, May 25, 2004; 62(10): 1804 - 1809. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rajput, C. A. Robinson, and A. H. Rajput Essential tremor course and disability: A clinicopathologic study of 20 cases Neurology, March 23, 2004; 62(6): 932 - 936. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Herlofson, S. A. Lie, D. Arsland, and J. P. Larsen Mortality and Parkinson disease: A community based study Neurology, March 23, 2004; 62(6): 937 - 942. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Spanaki and A. Plaitakis Bilineal transmission of Parkinson disease on Crete suggests a complex inheritance Neurology, March 9, 2004; 62(5): 815 - 817. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Foltynie, C. E. G. Brayne, T. W. Robbins, and R. A. Barker The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study Brain, March 1, 2004; 127(3): 550 - 560. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Papapetropoulos, A. A. Argiriou, and J. Ellul Clinical Characteristics of Late-Onset Parkinson Disease Arch Neurol, December 1, 2003; 60(12): 1815 - 1816. [Full Text] [PDF] |
||||
![]() |
E. D. Louis, G. Levy, H. Mejia-Santana, L. Cote, H. Andrews, J. Harris, C. Waters, B. Ford, S. Frucht, S. Fahn, et al. Risk of action tremor in relatives of tremor-dominant and postural instability gait disorder PD Neurology, October 14, 2003; 61(7): 931 - 936. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Marder, G. Levy, E. D. Louis, H. Mejia-Santana, L. Cote, H. Andrews, J. Harris, C. Waters, B. Ford, S. Frucht, et al. Accuracy of family history data on Parkinson's disease Neurology, July 8, 2003; 61(1): 18 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
K A Jellinger How valid is the clinical diagnosis of Parkinson's disease in the community? J. Neurol. Neurosurg. Psychiatry, July 1, 2003; 74(7): 1005 - 1006. [Full Text] [PDF] |
||||
![]() |
S. K. Van Den Eeden, C. M. Tanner, A. L. Bernstein, R. D. Fross, A. Leimpeter, D. A. Bloch, and L. M. Nelson Incidence of Parkinson's Disease: Variation by Age, Gender, and Race/Ethnicity Am. J. Epidemiol., June 1, 2003; 157(11): 1015 - 1022. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Foroud, S.K. Uniacke, L. Liu, N. Pankratz, A. Rudolph, C. Halter, C. Shults, K. Marder, P.M. Conneally, W.C. Nichols, et al. Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease Neurology, March 11, 2003; 60(5): 796 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Rao, L. Fisch, S. Srinivasan, F. D'Amico, T. Okada, C. Eaton, and C. Robbins Does This Patient Have Parkinson Disease? JAMA, January 15, 2003; 289(3): 347 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
D E Riley and T C Chelimsky Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson's disease J. Neurol. Neurosurg. Psychiatry, January 1, 2003; 74(1): 56 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Levy, M.-X. Tang, E.D. Louis, L.J. Cote, B. Alfaro, H. Mejia, Y. Stern, and K. Marder The association of incident dementia with mortality in PD Neurology, December 10, 2002; 59(11): 1708 - 1713. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Schrag, Y Ben-Shlomo, and N Quinn How valid is the clinical diagnosis of Parkinson's disease in the community? J. Neurol. Neurosurg. Psychiatry, November 1, 2002; 73(5): 529 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Foltynie, S Sawcer, C Brayne, and R A Barker The genetic basis of Parkinson's disease J. Neurol. Neurosurg. Psychiatry, October 1, 2002; 73(4): 363 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Shults, D. Oakes, K. Kieburtz, M. F. Beal, R. Haas, S. Plumb, J. L. Juncos, J. Nutt, I. Shoulson, J. Carter, et al. Effects of Coenzyme Q10 in Early Parkinson Disease: Evidence of Slowing of the Functional Decline Arch Neurol, October 1, 2002; 59(10): 1541 - 1550. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Stocchi, S. Ruggieri, L. Vacca, and C. W. Olanow Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease Brain, September 1, 2002; 125(9): 2058 - 2066. [Abstract] [Full Text] [PDF] |
||||
![]() |
W C Nichols, N Pankratz, S K Uniacke, M W Pauciulo, C Halter, A Rudolph, P M Conneally, and T Foroud Linkage stratification and mutation analysis at the parkin locus identifies mutation positive Parkinson's disease families J. Med. Genet., July 1, 2002; 39(7): 489 - 492. [Full Text] [PDF] |
||||
![]() |
K. Hedrich, K. Marder, J. Harris, M. Kann, T. Lynch, H. Meija-Santana, P. P. Pramstaller, E. Schwinger, S. B. Bressman, S. Fahn, et al. Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations Neurology, April 23, 2002; 58(8): 1239 - 1246. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. L. Lopez, J. T. Becker, D. I. Kaufer, R. L. Hamilton, R. A. Sweet, W. Klunk, and S. T. DeKosky Research Evaluation and Prospective Diagnosis of Dementia With Lewy Bodies Arch Neurol, January 1, 2002; 59(1): 43 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. K. Scott, M. A. Nance, R. L. Watts, J. P. Hubble, W. C. Koller, K. Lyons, R. Pahwa, M. B. Stern, A. Colcher, B. C. Hiner, et al. Complete Genomic Screen in Parkinson Disease: Evidence for Multiple Genes JAMA, November 14, 2001; 286(18): 2239 - 2244. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Martin, W. K. Scott, M. A. Nance, R. L. Watts, J. P. Hubble, W. C. Koller, K. Lyons, R. Pahwa, M. B. Stern, A. Colcher, et al. Association of Single-Nucleotide Polymorphisms of the Tau Gene With Late-Onset Parkinson Disease JAMA, November 14, 2001; 286(18): 2245 - 2250. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Hughes, S. E. Daniel, and A. J. Lees Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease Neurology, October 23, 2001; 57(8): 1497 - 1499. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Louis, G. Levy, L. J. Cote, H. Mejia, S. Fahn, and K. Marder Clinical Correlates of Action Tremor in Parkinson Disease Arch Neurol, October 1, 2001; 58(10): 1630 - 1634. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Abbott, H. Petrovitch, L. R. White, K. H. Masaki, C. M. Tanner, J. D. Curb, A. Grandinetti, P. L. Blanchette, J. S. Popper, and G. W. Ross Frequency of bowel movements and the future risk of Parkinson's disease Neurology, August 14, 2001; 57(3): 456 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Warmuth-Metz, M. Naumann, I. Csoti, and L. Solymosi Measurement of the Midbrain Diameter on Routine Magnetic Resonance Imaging: A Simple and Accurate Method of Differentiating Between Parkinson Disease and Progressive Supranuclear Palsy Arch Neurol, July 1, 2001; 58(7): 1076 - 1079. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Olanow, R. L. Watts, and W. C. Koller An algorithm (decision tree) for the management of Parkinson's disease (2001):: Treatment Neurology, June 12, 2001; 56(suppl_5): S1 - S88. [Full Text] [PDF] |
||||
![]() |
S Holroyd, L Currie, and G F Wooten Prospective study of hallucinations and delusions in Parkinson's disease J. Neurol. Neurosurg. Psychiatry, June 1, 2001; 70(6): 734 - 738. [Abstract] [Full Text] [PDF] |
||||
![]() |
G K Wenning, Y Ben-Shlomo, A Hughes, S E Daniel, A Lees, and N P Quinn What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? J. Neurol. Neurosurg. Psychiatry, April 1, 2000; 68(4): 434 - 440. [Abstract] [Full Text] [PDF] |
||||